After pretreatment with the FTO inhibitors CS1 or CS2, AML cells with high expression of LILRB4 were subsequently co-cultured with activated T cells, displaying that LILRB4 expression was significantly decreased and that the killing effect of T cells on AML cells was remarkably enhanced (101). The gene discussed is LILRB4; the disease is acute myeloid leukemia.